Efficacy and Safety of a Purified Standardised Bee Venom Preparation
Launched by ALLERGOPHARMA GMBH & CO. KG · Dec 9, 2005
Trial Information
Current as of May 08, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • History of bee venom allergy,
- • Positive RAST for bee venom,
- • Positive skin prick test for bee venom
- Exclusion Criteria:
- • Serious chronic diseases
About Allergopharma Gmbh & Co. Kg
Allergopharma GmbH & Co. KG is a leading research-driven biopharmaceutical company specializing in allergen immunotherapy and the development of innovative treatment solutions for allergic diseases. With a strong commitment to advancing patient care, Allergopharma focuses on high-quality product development and rigorous clinical trials to ensure the safety and efficacy of its therapies. Leveraging extensive expertise in allergy research, the company collaborates with healthcare professionals and academic institutions to enhance the understanding of allergic conditions and improve therapeutic outcomes for patients worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Reinbek, , Germany
Patients applied
Trial Officials
Annemie Narkus, M.D.
Principal Investigator
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials